 |
| |
|
|
|
|
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
eNewsletter: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Podcast: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
To successfully complete this activity, participants must read the content, then link to the Johns Hopkins University School of Medicine's CME Website to complete the post-test and, evaluation. Once you receive a passing grade, you can access and print your certificate of credit.
NOTE: If you have already registered for other Hopkins CME program at the CME website simply enter the requested information when prompted.
There is no fee for this activity.
This activity is supported by an educational grant from AstraZenca, Cubist Pharmaceuticals, and ViroPharma, Inc.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
This activity has been developed for the Primary Care Physician, Internist and Infectious Disease Specialist.
There are no prerequisites.
At the conclusion of this activity, participants should be able to:
- Identify current key topics related to the diagnosis and treatment of infectious disease conditions
- Discuss how the information presented may impact
current clinical paradigms
- Evaluate how the information presented may best
be incorporated into current clinical practice
November 2009; activities expire 2 years from the date of publication.
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Paul G. Auwaerter, MD, has disclosed that he has served as a consultant for Adamas Pharmaceuticals, LifeCell, Schering-Plough and Wyeth. He has also disclosed that he is a stock shareholder of Johnson and Johnson, Merck, and Pfizer.
John G. Bartlett, MD, has disclosed that he has received grants or research support from Salient.
Sara E. Cosgrove, MD, MS, has disclosed that she has received grants or research support from Astellas, Cubist, and AdvanDX and served as a consultant for Theravance/Astellas, Forest, and Merck.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
The Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K Modem or better, Windows Media Player 9.0 or later, 128 MB of RAM monitor settings: high color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader, storage, Internet connectivity, and minimum connection speed.
Presented by JHUSOM and in collaboration with DKBmed. |
|
|
|
|
